Home • Projects • Liraglutide – Next-Generation Antidiabetic Medication

Novo Nordisk’s NovoMix 30 is a unique insulin analogue that combines rapid and intermediate acting insulin aspart, providing the insulin requirement in a single injection.

«Back	|	Next»

---

Home | New On This Site | Products & Services | Company A-Z | Industry Projects | White Papers | Jobs & Careers | Press Releases | Events & Exhibitions | Newsletter | Organisations | About Us | Contact Us | Advertise With Us |